Skip to content

AvePoint stock hits 1-year high after analyst’s mega AVPT upgrade

AvePoint stock hits 1-year high after analyst’s mega AVPT upgrade
Ana Zirojevic

Not long after a Wall Street analyst increased their price target by a significant amount and retained a ‘buy’ recommendation, the stocks of independent software vendor for specialty SaaS solutions AvePoint (NASDAQ: AVPT) have skyrocketed to the highest level in 12 months.

Specifically, shortly upon Northland Securities raising their price target on AVPT shares from $12.00 to $18.00 alongside the ‘buy’ score, AvePoint stock started to increase in price, culminating with a one-year high, according to the most recent information retrieved by Finbold on June 21.

Why is AVPT stock up?

As it happens, the price increase for AvePoint shares started in May after the technology company posted strong first-quarter results that saw a substantial 25% year-over-year (YoY) increase in total revenue, to $74.5 million, which far surpassed the expected $71.7 million earlier predicted by Evercore ISI.

In response, Evercore ISI updated its outlook on AVPT stock, increasing the price target from $10 to $10.50, while retaining a ‘buy’ rating, more recently followed by Northland Securities analyst Nehal Chokshi, who updated his projection to an impressive $18 on June 17.

Other than this, AvePoint has recently received recognition in a form of addition to Inc.’s annual Best Workplaces list in the software industry, selected from thousands of applicants and evaluated by Quantum Workplace, according to the company’s press release from June 18.

AVPT stock forecast

As a result of the recent upgrades, the Wall Street analyst consensus on average price target for AVPT stock in the next 12 months has increased to $11.63, with three finance experts suggesting a ‘buy,’ one recommending a ‘hold,’ and with no ‘sell’ calls.

12-month AVPT stock price projections. Source: TipRanks
12-month AVPT stock price projections. Source: TipRanks

AVPT stock price analysis

For the time being, the price of AVPT stock stands at $9.93, suggesting an increase of 0.31% on the day, as well as a 7.06% gain across the past week, advancing 5.63% on its monthly chart, and recording an accumulated growth of 25.70% year-to-date (YTD), as per data on June 21.

 AvePoint stock price 1-week chart. Source: Finbold
AvePoint stock price 1-week chart. Source: Finbold

All things considered, AVPT stock might, indeed, make a further push upward towards the price set by Northland Securities or a more modest increase toward the average price offered by the group of Wall Street experts. However, trends in the stock market can shift, so doing one’s own research is critical.

Buy stocks now with eToro – trusted and advanced investment platform


Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk.

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in 70+ cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk. eToro USA LLC does not offer CFDs, only real Crypto assets available. Don’t invest unless you’re prepared to lose all the money you invest.

Read Next:

Weekly Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.